Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03660761
Recruitment Status : Completed
First Posted : September 7, 2018
Last Update Posted : April 16, 2019
Sponsor:
Information provided by (Responsible Party):
Rongjie Tao, Shandong Cancer Hospital and Institute